Guillain-Barré syndrome (GBS) is an auto-immune neurological disease that causes muscle weakness and paralysis, usually starting in the feet and hands, with about 20% of people still unable to walk at 6 months, and a global fatality rate of about 5%.
Back in 1976, a few hundred cases of Guillain-Barré syndrome triggered the stop of the notorious US swine flu vaccination campaign. Watch the excellent 1979 CBS report (15 minutes) about this episode or read the September 2020 New York Times piece about it.
Early reports of GBS after covid vaccinations were first ignored (‘no causality’) and then described as ‘extremely rare’. However, a quick search of publicly available case reports indicates that in the US alone, there may already be several hundred confirmed cases of post-vaccination GBS, both after mRNA and adenovector vaccines.
As with other serious vaccine adverse events, GBS may affect young and healthy people at low risk of severe covid. The case of a Nashville mother of three was recently covered by a local TV station. Both health authorities and people at low risk of severe covid may want to carefully examine the evidence concerning GBS and other non-trivial potential covid vaccine adverse events.
Case reports: Covid Vaccine Injuries (Telegram Web, 18+)
Update: On June 10, the German Paul Ehrlich Institute confirmed that GBS occurred “at an increased rate” after AstraZeneca vaccinations and might constitute a “new risk signal”. Note that GBS most certainly isn’t limited to AstraZeneca, which isn’t even used in the United States.
Update II: The latest on covid vaccine adverse events
- Vaccines: Successes and Controversies (15 documentaries)
- Covid vaccines: Post-vaccination deaths
- On the treatment of covid-19